Literature DB >> 25421784

Is mammography screening history a predictor of future breast cancer risk?

Sune Bangsbøll Andersen1, Sven Törnberg, Sini Kilpeläinen, My Von Euler-Chelpin, Sisse Helle Njor.   

Abstract

Inspired by the model by Walter and Day for risk of cervical cancer following negative screens, one might hypothesize that women in a mammography screening programme with a certain number of negative screens had a lower remaining breast cancer risk than that of women in general. We studied whether number of negative screens was a predictor for a low remaining breast cancer risk in women participating in the mammography screening programmes in Stockholm, Copenhagen and Funen. Data were collected from the mammography screening programmes in Stockholm, Sweden (1989-2012), Copenhagen, Denmark (1991-2009) and Funen, Denmark (1993-2009), and linked to the respective cancer registries. We calculated cumulative hazard rates for breast cancer in women in cohorts defined by age at entry and number of negative screens for the maximum follow-up period in each screening centre. For all centres and cohorts, the cumulative hazard were parallel for all number of negative screens, from after the time, when the women were scheduled to be invited for the next screen. This means that the remaining breast cancer risk is similar no matter how many negative screens a woman have had. Number of negative screens was not a predictor of a low remaining breast cancer risk in women participating in the mammography screening programmes in Stockholm, Sweden, Copenhagen and Funen, Denmark. The history of previous negative screens is therefore not suitable for personalisation of mammography screening.

Entities:  

Mesh:

Year:  2014        PMID: 25421784     DOI: 10.1007/s10654-014-9972-6

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  14 in total

Review 1.  Estimating the influence of rescreening interval on the benefits associated with cancer screening: approaches and limitations.

Authors:  Noel S Weiss; Ruth Etzioni
Journal:  Epidemiology       Date:  2002-11       Impact factor: 4.822

2.  Polygenes, risk prediction, and targeted prevention of breast cancer.

Authors:  Paul D P Pharoah; Antonis C Antoniou; Douglas F Easton; Bruce A J Ponder
Journal:  N Engl J Med       Date:  2008-06-26       Impact factor: 91.245

3.  Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.

Authors:  John T Schousboe; Karla Kerlikowske; Andrew Loh; Steven R Cummings
Journal:  Ann Intern Med       Date:  2011-07-05       Impact factor: 25.391

4.  Estimation of the duration of a pre-clinical disease state using screening data.

Authors:  S D Walter; N E Day
Journal:  Am J Epidemiol       Date:  1983-12       Impact factor: 4.897

5.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.

Authors:  M H Gail; L A Brinton; D P Byar; D K Corle; S B Green; C Schairer; J J Mulvihill
Journal:  J Natl Cancer Inst       Date:  1989-12-20       Impact factor: 13.506

Review 6.  European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document.

Authors:  N Perry; M Broeders; C de Wolf; S Törnberg; R Holland; L von Karsa
Journal:  Ann Oncol       Date:  2007-11-17       Impact factor: 32.976

7.  Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age.

Authors:  Ellen S O'Meara; Weiwei Zhu; Rebecca A Hubbard; Dejana Braithwaite; Karla Kerlikowske; Kim L Dittus; Berta Geller; Karen J Wernli; Diana L Miglioretti
Journal:  Cancer       Date:  2013-08-26       Impact factor: 6.860

8.  Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement.

Authors:  Hatef Darabi; Kamila Czene; Wanting Zhao; Jianjun Liu; Per Hall; Keith Humphreys
Journal:  Breast Cancer Res       Date:  2012-02-07       Impact factor: 6.466

Review 9.  The benefits and harms of breast cancer screening: an independent review.

Authors: 
Journal:  Lancet       Date:  2012-10-30       Impact factor: 79.321

10.  Individually tailored screening of breast cancer with genes, tumour phenotypes, clinical attributes, and conventional risk factors.

Authors:  Y-Y Wu; M-F Yen; C-P Yu; H-H Chen
Journal:  Br J Cancer       Date:  2013-05-14       Impact factor: 7.640

View more
  1 in total

1.  Number of prior negative screening outcomes does not influence future risk of breast cancer.

Authors:  Marie Lilleborge; Ragnhild S Falk; Solveig Hofvind
Journal:  Eur J Epidemiol       Date:  2020-05-19       Impact factor: 8.082

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.